No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
40 – 85
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
24 (estimated)
Sponsor
University of Pennsylvania · Other
Who this trial is looking for
This trial is looking for people who have mild aphasia due to a stroke that happened more than 6 months ago. Participants will receive Transcranial Magnetic Stimulation and speech therapy over 10 sessions and will have follow-up assessments after treatment.
Are You a Good Fit for This Trial?
You may be able to join if
I have had a stroke in the left side of my brain.
My stroke happened more than 6 months ago.
I have mild aphasia.
I can speak and understand English.
You may not be able to join if
I am currently abusing substances or alcohol.
I have other neurological disorders.
I have active psychiatric disorders.
I have a pacemaker or cardiac defibrillator.
I have tinnitus.
I have epilepsy or a seizure in the past 6 months.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
The goal of this clinical trial is to determine if Transcranial Magnetic Stimulation (TMS) combined with Speech-Language Therapy (SLT) is an effective treatment for mild aphasia in persons with chronic stroke.
The main questions this study aims to answer are:
1. Can TMS combined with SLT improve conversational speech and comprehension?
2. Can we identify specific behavioral and biological charac…
The goal of this clinical trial is to determine if Transcranial Magnetic Stimulation (TMS) combined with Speech-Language Therapy (SLT) is an effective treatment for mild aphasia in persons with chronic stroke.
The main questions this study aims to answer are:
1. Can TMS combined with SLT improve conversational speech and comprehension?
2. Can we identify specific behavioral and biological characteristics that would benefit most from the TMS and SLT treatment?
Researchers will compare real TMS to sham (fake) TMS to see whether TMS can treat post-stroke mild aphasia.
Participants will:
* Complete a screening and medical intake to determine eligibility
* Undergo a MRI
* Participate in 10 consecutive sessions (Monday-Friday) of TMS and SLT treatment
* Complete follow-up assessments 2 and 4 months after treatment
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Left Hemisphere stroke
* Stroke occurred more than 6 months ago
* Mild Aphasia (WAB AQ score \> 85)
* Proficient in English
Exclusion Criteria:
* Ongoing substance or alcohol abuse
* Other neurological disorders, beside stroke (i.e. dementia, traumatic brain injury, multiple…
Inclusion Criteria:
* Left Hemisphere stroke
* Stroke occurred more than 6 months ago
* Mild Aphasia (WAB AQ score \> 85)
* Proficient in English
Exclusion Criteria:
* Ongoing substance or alcohol abuse
* Other neurological disorders, beside stroke (i.e. dementia, traumatic brain injury, multiple sclerosis)
* Active psychiatric disorders (i.e. bipolar disorder, schizophrenia)
* Pacemaker or cardiac defibrillator
* Diagnosis of tinnitus
* Epilepsy, or seizure in the past 6 months
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.